Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors
- 1 June 2000
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 55 (6), 871-875
- https://doi.org/10.1016/s0090-4295(00)00489-1
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder.European Urology, 1999
- Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancerUrology, 1998
- EVALUATION OF NMP22 IN THE DETECTION OF TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 1998
- Improved detection of recurrent bladder cancer using the bard bta stat testUrology, 1997
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Cancer statistics, 1995CA: A Cancer Journal for Clinicians, 1995
- The Cell's Nucleus Shapes UpScience, 1993
- Biology and Management of Bladder CancerThe New England Journal of Medicine, 1990
- Prognostic Indices in Transitional Cell Carcinoma of the BladderBJU International, 1988
- Analysis of the performance of pathologists in the grading of bladder tumorsHuman Pathology, 1983